We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Sends an Untitled Letter for Cymbalta Ad
FDA Sends an Untitled Letter for Cymbalta Ad
January 29, 2010
Eli Lilly may be changing its ads promoting Cymbalta following an FDA untitled letter citing the company for failing to communicate risk in a consumer print ad and a WebMD Blue Book message, a Lilly spokesman says.